Chemotherapy-induced neuropathy in multiple myeloma: influence on quality of life and development of a questionnaire to compose common toxicity criteria grading for use in daily clinical practice-Reference-Cited by-同舟云学术

Chemotherapy-induced neuropathy in multiple myeloma: influence on quality of life and development of a questionnaire to compose common toxicity criteria grading for use in daily clinical practice

Published:2015-12-03 Issue:6 Volume:24 Page:2411-2420
ISSN:0941-4355
Container-title:Supportive Care in Cancer
language:en
Short-container-title:Support Care Cancer

Author:

Beijers A. J. M.,Vreugdenhil G.,Oerlemans S.,Eurelings M.,Minnema M. C.,Eeltink C. M.,van de Poll-Franse L. V.,Mols F.

Funder

Johnson and Johnson (US)

Jonker-Driessen Foundation

Pharos

Netherlands Organisation for Health Research and Development (NL)

Publisher

Springer Science and Business Media LLC

Subject

Oncology

Link

http://link.springer.com/content/pdf/10.1007/s00520-015-3032-y.pdf

Reference31 articles.

1. Jordan K, Proskorovsky I, Lewis P, Ishak J, Payne K, Lordan N, et al. (2014) Effect of general symptom level, specific adverse events, treatment patterns, and patient characteristics on health-related quality of life in patients with multiple myeloma: results of a European, multicenter cohort study. Support Care Cancer 22:417–426

2. Mols F, Oerlemans S, Vos AH, Koster A, Verelst S, Sonneveld P, et al. (2012) Health-related quality of life and disease-specific complaints among multiple myeloma patients up to 10 yr after diagnosis: results from a population-based study using the PROFILES registry. Eur J Haematol 89:311–319

3. Delforge M, Blade J, Dimopoulos MA, Facon T, Kropff M, Ludwig H, et al. (2010) Treatment-related peripheral neuropathy in multiple myeloma: the challenge continues. Lancet Oncol 11:1086–1095

4. Jongen JL, Broijl A, Sonneveld P (2015) Chemotherapy-induced peripheral neuropathies in hematological malignancies. J Neuro-Oncol 121:229–237

5. Hershman DL, Lacchetti C, Dworkin RH, Lavoie Smith EM, Bleeker J, Cavaletti G, et al. (2014) Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol 32:1941–1967

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the Potential Role of Phytopharmaceuticals in Alleviating Toxicities of Chemotherapeutic Agents;Current Protein & Peptide Science;2024-12

2. Cured but not well — haematological cancer survivors’ experiences of chemotherapy-induced peripheral neuropathy in everyday life: a phenomenological-hermeneutic study;Journal of Cancer Survivorship;2024-05-14

3. Bortezomib-induced peripheral neuropathy: Clinical features, molecular basis, and therapeutic approach;Critical Reviews in Oncology/Hematology;2024-05

4. Acute, long-term or non-vincristine-induced peripheral neuropathy among non-Hodgkin lymphoma survivors: Symptoms, daily activities, functional status, and quality of life;European Journal of Oncology Nursing;2024-04

5. Pain management in patients with multiple myeloma;Douleurs : Évaluation - Diagnostic - Traitement;2024-02